According to a recent study, a newly discovered biomarker, free water, can track changes in the brain that are associated with Parkinson’s disease, which ultimately may aid in developing new drugs that could slow disease progression. “This finding is a potential game changer as it could shift the way Parkinson’s disease clinical…
Parkinson’s disease patients have a significantly higher risk of developing melanoma, and the opposite is also true, according to a new study. But researchers aren’t sure of the cause. The study, “Parkinson Disease and Melanoma: Confirming and Reexamining an Association,” was published in the journal Mayo Clinic Proceedings.
New research shows that alpha-synuclein is expressed in the enteroendocrine cells (EECs) of the intestine, which are directly connected to nerves that contain α-synuclein, forming a neural circuit between the gut and the nervous system. In this manner, external toxins and other environmental influences could aid in the misfolding of…
Australia’s GKC (Global Kinetics Corp.) has enrolled the first of more than 400 Parkinson’s patients in its APPRISE clinical trial — a multicenter, randomized study that will determine whether the Personal KinetiGraph (PKG) system is appropriate for identifying which patients need to change the clinical management of their disease. The trial,…
Get regular updates to your inbox.